JAMA

@jama.com

JAMA is an international peer-reviewed general medical journal and a member of the JAMA Network family of journals. 🌐 JAMA.com

Online #GLP1 receptor agonist prescribing often lacks direct clinician interaction, relying mainly on questionnaires and issuing prescriptions quickly—even for compounded, non-FDA-approved formulations. ja.ma/4w3xdfW

JAMA research letter, published July 6, 2026: 'Online Prescribing of GLP-1 Receptor Agonists.' Table 2 details GLP-1 RA characteristics from online sellers (N=45). Most are compounded (86.7%), subcutaneous (86.7%), include supplements (60%), and are automatically shipped (75.6%).

💬 Editor's Note: The US Food and Drug Administration and the Federal Trade Commission provide limited oversight for low-risk #DigitalHealth wellness devices, aiming to preserve innovation while requiring truthful, substantiated claims. ja.ma/454dSAs

JAMA article "AI IN MEDICINE: Regulation of General Wellness Devices" by Gregory Curfman, MD, published August 3, 2026. It discusses oversight and regulatory framework for digital health and wellness products like wearables/apps, FDA/FTC roles, and future challenges in distinguishing wellness from medical devices.

💬 Editor's Note: The US Food and Drug Administration and the Federal Trade Commission provide limited oversight for low-risk #DigitalHealth wellness devices, aiming to preserve innovation while requiring truthful, substantiated claims. ja.ma/45CaOLW

A JAMA article titled "Regulation of General Wellness Devices" by Gregory Curfman, MD, published online August 3, 2026, under 'AI IN MEDICINE'. The text discusses oversight of digital health products like wearables and apps, and regulatory challenges.

💬 Perspective: Much of today’s #WearableData may function as results of unknown significance, appearing clinically useful without clear evidence, reference ranges, or defined roles in diagnosis and treatment. ja.ma/4pZ5sUE

JAMA article: 'AI IN MEDICINE: Sorting Results of Unknown Significance—A Framework for Clinicians Navigating Wearable Data in the AI Era.' Includes a table classifying patient-generated & device-derived health data by clinical validity & actionability in 5 categories.

💬 Viewpoint: Under the US Food and Drug Administration January 2026 guidance, many low-risk #DigitalHealth tools fall outside medical device oversight, but some may still influence health decisions without clear evidence standards. ja.ma/4cg8b66

JAMA article, 'The Need to Avoid a Regulatory Gray Zone in Digital Wellness' by John J. Whyte, MD, MPH, published online August 3, 2026. A 'VIEWPOINT' in 'AI IN MEDICINE', discussing consumer-facing digital health technologies & FDA regulation.

In this podcast, JAMA Deputy Editors Linda Brubaker, MD, and Christopher Muth, MD, discussed the latest science: ➡️ Elevated LDL Cholesterol and Global Burden of Disease Analysis, ➡️ Intervention for Growth in Small-for-Gestational-Age Infants, and more. ja.ma/4fxPpcK

Two JAMA journal covers are stacked, prominently displaying the 'JAMA' logo. Visible text includes 'Research', 'Opinion', and 'Viewpoint'. Below, the article title reads 'Elevated LDL Cholesterol and Global Burden of...' from a 'JAMA Editors' Summary'.

A text-delivered video #SafeSleep intervention for low-income families did not significantly improve reported usual supine sleep, room sharing without bed-sharing, soft bedding nonuse, or pacifier use. ja.ma/4fRTeII

JAMA "Original Investigation" article titled "Safe Sleep Video Intervention via Text Messaging to Low-Income Families: The SMARTER Randomized Clinical Trial." Authors: Rachel Y. Moon et al. Published Online: July 23, 2026. DOI: 10.1001/jama.2026.9119.

📊 JAMA Clinical Guidelines Synopsis: The newly released Surviving #Sepsis Campaign guidelines endorse early broad-spectrum antibiotics, rapid fluid resuscitation, and deescalation strategies for adults with sepsis or septic shock. ja.ma/4xBQHtx

JAMA Clinical Guidelines Synopsis for "Caring for Adult Patients With Sepsis," published online March 26, 2026. Authored by Christopher W. Seymour et al., these are the Surviving Sepsis Campaign 2026 International Guidelines for adults at risk.

📌 How can clinicians and researchers stay up to date on the most clinically relevant trials? Follow JAMA+ Trials to get curated access to the best of the JAMA Network’s trial research, commentaries, and educational resources: jamanetwork.com/channels/tri...

JAMA+ Trials Research, Education and Commentary from JAMA Network

Find high-quality clinical trial research with JAMA+ Trials, offering curated studies, multimedia insights, and advanced search across the JAMA Network.

jamanetwork.com

JAMA Neurology EIC S. Andrew Josephson, MD, selected this as his 2025 Editor's Choice: Clinical Trial of the Year for its important findings on relapse risk after discontinuing disease-modifying therapy in stable MS. 🔗 Read the Editorial: ja.ma/3S5wbSN

Bild

Ten years after the US Centers for Disease Control and Prevention first issued #opioid prescribing guidance, clinicians are still balancing caution about #addiction risk with the need to treat pain effectively. 🎙️ Listen: ja.ma/4g7pdpn

Balance scale cartoon showing 'PAIN RELIEF PATIENT NEEDS' on one side and 'ABUSE ADDICTION DIVERSION' on the other, with connected opioid molecules in the center. Below the image, text reads: 'Striking the Balance for Prescribing Opioids'.

Lifestyle interventions, anti-tau therapy, and treatment for agitation in #Dementia were among the major topics discussed from #AAIC2026. 🎧 Listen to Gil Rabinovici, MD, discuss this and more with JAMA Medical News’ Rita Rubin: ja.ma/4cirdsC

Stylized graphic of a head with medical icons (stethoscope, pills, syringe, Rx, caduceus, ambulance, thermometer, EKG) emerging. Title: Highlights From the 2026 Alzheimer's Association... Below: July 31, JAMA Medical News, 31m playtime.

From 2011 to 2024, #Alcohol use, binge drinking, and heavy drinking increased among pregnant women in the US, indicating ongoing public health concerns about prenatal alcohol exposure. ja.ma/4wuHG5b

JAMA Research Letter: Trends in Alcohol Consumption During Pregnancy in the US. Two line graphs show past-month alcohol use in nonpregnant and pregnant women (2011-2024). Nonpregnant women have stable, high rates. Pregnant women have lower rates, but show increasing trends in current use, binge, and heavy drinking.